We are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.
Donations are welcome
Heavy drinking and the problematic use of alcohol are widely thought to be relevant factors in assessing an individual’s risk for suicidal behavior. It has been the role of research to investigate exactly how alcohol use and suicidality are related.
Associate Professor
Virginia Commonwealth University
2016 Young Investigator Grant
Associate Professor of Psychiatry
Associate Director, Center for Neuromodulation in Depression and Stress
Co-Director, Penn Brain Science, Translation, Innovation, and Modulation Center (brainSTIM)
Staff Therapist, Penn Center for the Treatment and Study of Anxiety
Director, Center for Brain Imaging and Stimulation
University of Pennsylvania
2016 Young Investigator Grant
As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses, including OCD), researchers seek to understand how and why it is able to help reduce symptoms in patients who respond positively.
Assistant Professor, Institute of Behavioral Science
Feinstein Institutes for Medical Research
2018 Young Investigator Grant
Dr. Hengyi Cao is an assistant professor at the Feinstein Institutes for Medical Research and Zucker Hillside Hospital. He has been conducting neuroimaging research in psychiatry for more than 10 years and has extensive experience in psychiatric neuroimaging and clinical neuroscience. Dr. Cao has published more than 30 first-authored papers in leading journals and has served as a reviewer for more than 40 journals in the field. He has received awards from multiple research societies and foundations, including the Schizophrenia International Research Society, Society of Biological Psychiatry and the Brain and Behavior Research Foundation.
In people who experience a first psychotic episode—often the prelude to schizophrenia and related disorders—the individual’s response to antipsychotic medicines can be crucial, and typically, varies considerably from patient to patient.
In the weeks, months, and even years following a COVID infection, it is not uncommon for those who have recovered from the virus’s acute symptoms to be dogged by persistent depressive symptoms. Often, such depression is accompanied by cognitive symptoms; sometimes the latter can occur in the absence of depression symptoms. Researchers have been trying to get a fix on what causes these post-infection brain-based symptoms, and a new study suggests one possible source.
In recent years, a steadily growing body of evidence has indicated an association between elevated levels of inflammation and psychiatric illness.
Professor of Neuroscience and Physiology
SUNY Upstate Medical University
Macquarie Group Foundation Chair of Schizophrenia Research
University of New South Wales and the Neuroscience Research Australia
2004 Independent Investigator Grant
2001, 1999 Young Investigator Grant
